Apeel Sciences

Valuation $2B

About Apeel Sciences

Apeel Sciences develops plant-derived shelf life extension technology for fresh produce that improves quality and reduces food waste.
Headquarters Apeel Sciences, Goleta
Founded 2012-01-01
Industry Agriculture, AgTech, Biotechnology, Food and Beverage, Sustainability
Last Funding Type Series Unknown
Valuation 2
Total Funding $719.06 million dollars
IPO Status Private

Financial

Apeel Sciences may be growing as it has introduced a new produce ripening technology, which indicates an expansion of its product offerings. The introduction of new technology suggests that the company is innovating and potentially increasing its market reach. This development could lead to an increase in revenue streams and market share within the agriculture and sustainability sectors.

Apeel Sciences is focused on enhancing food quality and shelf life through various innovative methods. They are developing UV and machine learning-based techniques to assess food item quality and predict shelf life. Their research includes antimicrobial treatments, protective coatings, and methods for sanitizing produce. They are also exploring gas phase treatments to delay ripening and mitigate infections in produce. Apeel Sciences is investigating the use of hyperspectral imaging for quality assessment and foreign object identification, as well as machine learning for predicting infection likelihood in plant products. Their R&D efforts extend to plasma treatment systems for edible coatings and controlled droplet applicators for hygienic fluid dispensing. Each area of research aims to improve the longevity and safety of fresh produce.

Apeel Sciences announced a new CEO, marking a significant milestone in its journey. The company also launched 'The Apeel Leverage' initiative aimed at transforming operational efficiencies and expanding market reach. These developments highlight efforts to enhance leadership and improve business operations.
Funding Rounds 12
Number of Lead Investors 3
Total Funding Amount  $719.06 million dollars
Number of Investors 40

Related Angels

John Petote
View profile